Enantioselective reductive desymmetrization of glutarimides has been achieved employing an oxazaborolidine catalyst derived from cis-1-amino-indan-2-ol. The reaction was found to proceed through a stereoablative process that upgraded the enantioselectivity of an intermediate hydroxy-lactam. The reaction was generally tolerant of a number of substituents in the 4-position, giving enantiomeric excesses of greater than 82%.
Introduction Scheme 1. Route to glutarimide substrates
protected 3-phenylglutarimide 3 using both B-OMe catalyst 7 and B-Me catalyst 8 employing BH 3 .THF as borane source. Two methods of preparing the catalysts were evaluated; the first involved preparing the stock solution of the catalyst in situ at room temperature and using it immediately, while the second involved repeated azeotropic distillations before the final stock solution of the catalyst was made. In all cases, monitoring of the reaction by TLC indicated an optimum conversion to product after 3 h, and therefore the reactions were stopped at this point and the crude mixture reduced with triethylsilane to convert the intermediate hydroxyl-lactam to the more stable 2-piperidinone 10a to aid analysis (Scheme 2, Table 2 ). In all cases, the presence of the piperidine 11a was observed, formed by over-reduction of the intermediate hydroxy-
lactam. This relatively rapid formation of the doubly reduced product was observed in earlier work on related N-PMP five membered imides.
14 Scheme 2. Reduction of meso-glutarimides 3, 4a, 5 and 6. prepared by mixing (1R, 2S)-cis-1-aminoindan-2-ol (1.00 mmol) and either trimethylborate (0.10 mL, 1.00 mmol) or trimethylboroxine (0.05 mL, 0.33 mmol) in THF (3 mL) and allowing to stir for 45 min, before dilution to 5 mL with THF. e Catalyst prepared by reaction of (1R, 2S)-cis-amino-2-indanol (1.00 mmol) in dry toluene (3 mL) with either trimethylboroxine (0.33 mmol) or trimethylborate (1.00 mmol) and allowed to stir for 30 min before azeotropic distillation with dry toluene. Dry dichloromethane (5 mL) was added to give a stock solution of the catalyst. f ND -not determined.
When using the N-PMP substrate 3 with the B-OMe catalyst, both methods of preparation gave excellent ee's of piperidinone 10a, however method A produced the 2-piperidinone 10a in a 48%
yield and the undesired piperidine 11a in a 21% yield ( Table 2 , entry 1) while method B gave 43% yield of the desired product 10a and 15% of the undesired product 11b ( Table 2 , entry 2).
For the B-Me catalyst, a significant difference in both yield and enantioselectivity was observed for the two methods of preparing the catalyst (Table 2 , entries 3 and 4). Only 18% yield and 53% ee of the desired product was obtained when the catalyst was prepared in situ at room temperature while for the method involving azeotropic distillation gave 33% yield of the desired product in 95% ee. The undesired over-reduced product was also increased from 10% to 30%.
The desymmetrisation of 3-phenyl N-benzyl glutarimide analogue 4a was also explored using both B-Me and B-OMe catalysts ( Table 2 , entries [5] [6] [7] [8] . The formation of the piperidine product 11b was significantly slower compared to N-PMP glutarimide 3 which allowed the reaction time to be extended to as long as 24 hours. As expected, a slight decrease in selectivity was observed with both catalysts showing consistency with observations from earlier work on five-membered meso-imides. 12 As with the PMP substrates, the B-OMe catalyst gave rather disappointing results, but again, use of the repetitive azeotropic distillation protocol for the preparation of B-
Me catalyst led to a significant increase in the yield of the desymmetrised product, from 33% (Table 2 , entry 4) to 60% ( Table 2 , entry 8), with only a slight decrease in enantioselectivity.
Thus, this was adopted as the optimum catalyst and procedure. For comparison purposes, desymmetrisation of N-benzyl-4-phenylpiperidin-2,5-dione 4a using these optimised conditions with a catalyst prepared in situ from (S)-(-)-, -diphenyl-2-pyrrolidinemethanol 9 gave only 13% yield and 14% ee of the lactam product 10b (Table 2, entry 10 ). This showed a remarkable superiority of oxazaborolidines derived from cis-1-amino-indan-2-ol over those derived from , -diphenyl prolinol with these substrates.
Since the change in nitrogen protecting group afforded a significant increase in yield, use of modified benzyl protecting groups (2-methylbenzyl and 2-methoxybenzyl) was probed, but this led to a significant fall in yield (25% and 21%, respectively) but kept the ee at excellent levels (Table 2, entries 11 & 12) . This further reinforces the delicate nature of the N-protecting groups in influencing the yield and / or selectivity of the oxazaborolidine mediated desymmetrisation.
Hence N-benzyl was chosen as the optimum protecting group for further exemplification. probing the effect of the nitrogen protecting group on the stereoablative process are underway.
The optimum catalyst system (Table 2, entry 8) was then applied to the remainder of the Nbenzyl glutarimides 4b-i over a 24 hour period in an attempt to maximise yield and / selectivity.
All 4-aryl substrates 4a-e furnished the chiral 2-piperidinones 13b i in moderate yields (51 61%) and excellent enantioselectivities of 82 92% ee (Scheme 4 and Table 3 , entries 1 4).
However, a notable decrease in both yield and ee was observed when the aryl group was changed to 1-naphthyl (Table 3 , entry 6). A change from 4-substituted aryls to 4-substituted alkyls 3g i was well tolerated but a slight drop in the yield of the products was noticeable (Table 3, entries 6-8) . As expected, residual starting material and over-reduced piperidine products were observed in variable quantities in the 1 H NMR spectrum of all unpurified reaction mixtures, but in these examples, only the 2-piperidinone was isolated and characterised. ].
Scheme 4. Desymmetrisation of N-Bn glutarimides using B-Me catalyst
To explain the stereochemical outcome, two possible pre-transition state intermediates involving the imide and the borane-activated oxazaborolidine catalyst can be imagined ( Figure 1 ). The models are based on the assumption that the catalyst is co-ordinated to the least hindered In conclusion, an efficient strategy for the highly enantioselective desymmetrisation of glutarimides using oxazaborolidines has been developed, providing an efficient method to access important piperidine building blocks. This strategy appears to be heavily reliant on catalysts derived from cis-1-amino-indan-2-ol. Further evidence has also been accrued for a stereoablative upgrade of enantioselectivity through a double stereo-differentiation process with N-PMP-3-phenyl glutarimide substrate, and more experiments probing this process are underway.
Experimental Section

General experimental methods
All solvents were obtained dry from a dry solvent system and glassware was flame dried and cooled under vacuum before use. All dry reactions were carried out under a nitrogen atmosphere.
TLC was carried out using aluminium TLC sheets (silica gel 60 F 254 ), and was performed using a HCl (10 mL) was heated at reflux for 24 h. The conc. HCl was evaporated to about 4 mL and fresh conc. HCl (10 mL) was added and further heated at reflux for additional 24 h. The mixture was allowed to cool to room temperature, the solid was filtered and recrystallized from EtOAc / petroleum ether (40-60).
General Procedure B for the synthesis of 3-(p-substituted phenyl) glutaric acids.
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A solution of p-substituted benzaldehyde (1 equiv.) × 10 -1 mbar) to leave the crude tetraethyl 2-(ortho or para substituted phenyl)propane-1,1,3,3-tetracarboxylate as an oily residue which was taken to the next synthetic step without further purification. This material was dissolved in conc. HCl (10 mL) was heated at reflux for 24 h. The conc. HCl was evaporated to about 4 mL and fresh conc. HCl (10 mL) was added and further heated at reflux for additional 24 h. The mixture was allowed to cool to room temperature, the solid was filtered and recrystallized from EtOAc / petroleum ether (40-60).
General Procedure C for the synthesis of 3-isopropyl & 3-tert-butyl glutaric acids
A mixture of isobutyraldehyde or trimethylacetaldehyde (1.0 equiv.), ethylcyanoacetate (1.0 equiv.) and piperidine (0.01 equiv.) in toluene (40 mL) was heated at reflux for 4 hours and allowed to cool to room temperature. The solvent was removed in vacuo and the residue was dissolved in CH 2 Cl 2 (30 mL), dried over MgSO 4 and filtered. The solvent was evaporated in vacuo to give an orange oily residue which was added to a solution of dimethylsodiomalonate [made from dimethylmalonate (1.0 equiv.) and sodium (0.1 equiv.) in dry MeOH (20 mL)]. The mixture was heated at reflux for 17 h, allowed to cool to room temperature and acidified with 1M HCl (15 mL). The mixture was then extracted with ether (5 × 60 mL) and the combined ethereal fractions were washed with water (60 mL), dried over MgSO 4 and filtered. The ether was evaporated under reduced pressure to give the crude cyanotricarboxylate as orange oil. The crude cyanotricarboxylate in conc. HCl (10 mL) was heated at reflux for 24 h. The conc. HCl was evaporated to about 4 mL and fresh conc. HCl (10 mL) was added. The reaction mixture was again heated at reflux for additional 24 h. The mixture was allowed to cool to room temperature, poured in to ice / water mixture (50 mL) and extracted with ether (5 × 30 mL). The combined ethereal portions were washed with water (20 mL), dried over MgSO 4 , filtered and solvent evaporated in vacuo to obtain a dark brown liquid which upon standing in fridge turned to brown solid, which was purified by recrystallisation from EtOAc / hexane.
3-(2-Fluorophenyl)pentan-1,5-dioic acid 1b
Using general procedure A starting with ( General Procedure D for the synthesis of glutaric anhydrides.
3-(4-Fluorophenyl)pentan-1,5-dioic acid 1c
16
A mixture of glutaric acid in acetyl chloride (30 mL) was heated at reflux for 48 h. The mixture was cooled to room temperature and the acetyl chloride was removed in vacuo to give brown liquid which was purified by recrystallisation. given for the compound in the literature.
4-Phenyldihydropyran-2,6-dione 2a
4-(1-Naphthyl)dihydropyran-2,6-dione 2f
Using general procedure D starting with glutaric acid 1f (3.00 g, 0.01 mol), the title compound 2f General Procedure E for the synthesis of glutarimides.
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The corresponding amine (1.0 equiv) was slowly added to a solution of the glutaric anhydride (1.0 equiv) and triethylamine (1.0 equiv) in dry THF (30 mL). The mixture was heated at reflux for 48 h, cooled to room temperature and concentrated under reduced pressure. Dichloromethane The solvent was removed in vacuo to give a brown solid which was purified by recrystallization.
N-(4-Methoxyphenyl)-4-phenylpiperidin-2,6-dione 3
Using general procedure E starting with 3-phenylglutaric anhydride 2a ( 
1-(Phenylmethyl)-4-phenylpiperidin-2,6-dione 4a
Using general procedure E starting with 3-phenylglutaric anhydride 2a (1.50 g, 7.89 
1-(Phenylmethyl)-4-(2-fluorophenyl)piperidin-2,6-dione 4b
Using general procedure E starting with glutaric anhydride 2b (2.00 g, 9.62 mmol), benzylamine (1.10 mL, 9.62 mmol) and triethylamine (1.34 mL, 9.62 mmol), the title compound 4b was 
1-(Phenylmethyl)-4-(2-methylphenyl)piperidin-2,6-dione 4d
Using general procedure E starting with glutaric anhydride 2d (1.50 g, 7.35 
1-(Phenylmethyl)-4-(4-methylphenyl)piperidin-2,6-dione 4e
Using general procedure E starting with glutaric anhydride 2e (5.00 g, 24.5 mmol), benzylamine (2.67 mL, 24.5 mmol) and triethylamine (3.40 mL, 24.5 mmol), the title compound 4e was 
1-(Phenylmethyl)-4-(1-naphthyl)piperidin-2,6-dione 4f
Using general procedure E starting with glutaric anhydride 2f ( 
1-(Phenylmethyl)-4-methylpiperidin-2,6-dione 4g
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Using general procedure E starting with glutaric anhydride 2g (3.50 g, 27.3 mmol), benzylamine (2.93 g, 27.3 mmol) and triethylamine (3.82 mL, 27.3 mmol), the title compound 4g was 
1-(Phenylmethyl)-4-isopropylpiperidin-2,6-dione 4h
Using general procedure E starting with glutaric anhydride 2h (2.00 g, 12.8 mmol), benzylamine (1.37 g, 12.8 mmol) and triethylamine (1.80 mL, 12.8 mmol), a yellowish liquid was obtained that turned to a yellowish solid upon standing. The solid was purified via flash column chromatography eluting with EtOAc / petroleum ether (40-60) (3:7) to afford the title compound 4h as colourless liquid which turned to a white solid upon standing (2.10 g, 67%); mp = 
1-(Phenylmethyl)-4-tert-butylpiperidin-2,6-dione 4i
Using general procedure E starting with glutaric anhydride 2i (1.30 g, 7. 65 mmol), benzylamine (0.89 g, 7.65 mmol) and triethylamine (1.10 mL, 7.65 mmol), a yellowish solid was obtained.
The solid was purified via flash column chromatography eluting with EtOAc : petroleum ether 2.83 (dd, J = 17.0, 3.8 Hz, 2H), 4.96 (s, 2H), 3H), 2H) 
1-(2-Methylphenylmethyl)-4-phenylpiperidin-2,6-dione 5
Using general procedure E starting with 3-phenylglutaric anhydride 2a (1.70 g, 8.95 
1-(2-Methoxyphenylmethyl)-4-phenylpiperidin-2,6-dione 6
Using general procedure E starting with 3-phenylglutaric anhydride 2a (2.00 g, 10.5 mmol), 2-methoxybenzylamine (1.37 mL, 10.5 mmol) and triethylamine (1.47 mL, 10.5 mmol) , the title compound 6 was obtained as white crystals by recrystallization from EtOAc / petroleum ether (40-60) (1.97 g, 60%); mp = 98-100 o C; Anal. Calcd for C 19 H 19 NO 3 : C, 73.77; H, 6.19; N, 4.53. Found: C, 73.50; H, 6.06; N, 4.44 = 17.1, 11.5 Hz, 2H), 3.08 (dd, J = 17.1, 4.3 Hz, 2H), 3.44 (tt, J = 11.5, 4.3 Hz, 1H), 3.86 (s, 3H), 5.08 (s, 2H), 3H), 3H), 1H), 2H) General Procedure F for the asymmetric reduction of 4-phenylglutarimides using B-OMe catalyst 7 followed by conversion to the corresponding lactam A solution of (1R, 2S)-cis-1-amino-indan-2-ol (0.15 g, 1.00 mmol) in THF (3 mL) was treated with trimethylborate (0.10 mL, 1.00 mmol) and allowed to stir for 45 min. The solution was then diluted to 5 mL by further addition of THF, to give the catalyst 7 as a stock solution. The glutarimide (1.00 mmol) was dissolved in dry DCM (30 mL) under a nitrogen atmosphere and this solution was treated with the catalyst stock solution (0.50 mL, 10 mol%) then a drop-wise addition of BH 3 .THF (1.00 mL, 1.00 mmol), and allowed to stir at rt for 3 h (for N-PMP glutarimide) or 24 h (for N-Bn glutarimide). The reaction was quenched by the addition of MeOH (5 mL) and 1M HCl (5 mL), and extracted with CH 2 Cl 2 (3 × 15 mL). The combined organic extracts were dried over MgSO 4 and filtered. The solvent was removed in vacuo to give the crude hydroxy-lactam as a white powder which was immediately re-dissolved in CH 2 Cl 2 (25 mL) and treated with TFA (1 mL) and triethylsilane (1 mL) in CH 2 Cl 2 (5 mL). This mixture was allowed to stir at rt for 1 h, after which the solution was added to an ice-water mixture (15 mL) followed by extraction with CH 2 Cl 2 (3 × 15 mL). The combined organic extracts were washed with saturated NaHCO 3 (15 mL), dried over MgSO 4 and filtered. The solvent was removed in vacuo to give a white solid, which was purified via flash column chromatography.
General Procedure G for the asymmetric reduction of glutarimides using B-Me catalyst 8
followed by conversion to the corresponding lactam A suspension of (1R, 2S)-cis-amino-2-indanol (0.15 g, 1.00 mmol) in dry toluene (3 mL) was treated with trimethylboroxine (0.05 mL, 0.33 mmol) and allowed to stir under nitrogen for 30 min. Dry toluene (5 mL) was added and the reaction distilled until approximately 2 mL of solvent remained. This procedure was repeated twice after which the final volume of toluene was removed under pressure to give a yellow solid. Dry dichloromethane (5 mL) was added to give a stock solution of the B-Me catalyst 8. The catalyst (0.5 mL, 10 mol %) was added to the solution of the glutarimide substrate (1.00 mmol) in dry dichloromethane (30 mL) followed by a dropwise addition of BH 3 .THF (1 mL, 1.00 mmol). The solution was then allowed to stir at room temperature for 3 h (for N-PMP glutarimide) or 24 h (for N-Bn glutarimides). The reaction was finally quenched by addition of MeOH (2 mL) and 1M HCl (2 mL), extracted with CH 2 Cl 2 (3 × 15 mL), dried over MgSO 4 and filtered. The solvent was evaporated in vacuo to give the crude hydroxy-lactam as a white powder which was immediately re-dissolved in CH 2 Cl 2 (30 mL) and treated with TFA (1 mL) and triethylsilane (1 mL) in CH 2 Cl 2 (5 mL). This mixture was allowed to stir at rt for 1 h, after which the solution was added to an ice-water mixture (15 mL) followed by extraction with CH 2 Cl 2 (3 × 15 mL). The combined organic extracts were washed with saturated NaHCO 3 (3 × 15 mL), dried over MgSO 4 and filtered. The solvent was removed in vacuo to give a crude white solid, which was purified via flash column chromatography eluting with EtOAc / petroleum ether (40-60) (7:3) .
Procedure for the asymmetric reduction of N-(benzyl)-4-phenylpiperidin-2,6-dione 4a using catalyst 9 followed by conversion to the corresponding lactam 10b
A suspension of (S)-(-)-, -diphenyl-2-pyrrolidinemethanol (0.25 g, 1.00 mmol) in dry toluene (3 mL) was treated with trimethylboroxine (0.05 mL, 0.33 mmol) and allowed to stir under nitrogen for 30 min. Dry toluene (5 mL) was added and the reaction distilled until approximately 2 mL of solvent remained. This procedure was repeated twice after which the final volume of toluene was removed under pressure to give a yellow solid. Dry dichloromethane (5 mL) was added to give a stock solution of the B-Me CBS catalyst. The catalyst (0.50 mL, 10 mol %) was added to the solution of the glutarimide substrate 4a (0.28 g, 1.00 mmol) in dry dichloromethane (30 mL) followed by a drop-wise addition of BH 3 .THF (1 mL, 1.00 mmol). The solution was then allowed to stir at room temperature for 24 h. The reaction was finally quenched by addition of MeOH (2 mL) and 1M HCl (2 mL), extracted with CH 2 Cl 2 (3 × 15 mL), dried over MgSO 4 and filtered. The solvent was evaporated in vacuo to give the crude hydroxy-lactam as a white powder which was immediately re-dissolved in CH 2 Cl 2 (30 mL) and treated with TFA (1 mL) and triethylsilane (1 mL) in CH 2 Cl 2 (5 mL). This mixture was allowed to stir at rt for 1 h, after which the solution was added to an ice-water mixture (15 mL) followed by extraction with Hz, 1.9 Hz, 1H), 3.29 (tdd, J = 10.8, 5.3 Hz, 3.4 Hz, 1H), 3.65 (ddd, J = 10.8, 5.3, 3.4 Hz, 1H 
(4R)-1-(2-Methylbenzyl)-4-phenylpiperidin-2-one 10c
Using glutarimide 5 (0.30 g, 1.00 mmol) the title compound 10c was obtained as a white solid using general procedure G (0.07 g, 25% over 2 steps, 88% ee determined by HPLC on a Lux 3 CELLULOSE-2 column (hexane/2-propanol = 80/20, flow rate = 1.0 mL/min, t major = 20.6 min, 6.97 (td, J = 7.5, 0.9 Hz, 1H), 5H), 2H) (27), 149 (35) , 121 (60), 91 (85).
1-(4-Methoxyphenyl)-4-phenylpiperidine 11a
Using general procedure G and glutarimide 3 (0.30 g, 1.00 mmol) the title compound 11a was obtained as white crystals (0.08 g, 30% over 2 steps); mp = 150-152 o C; Anal. Calcd for C 18 H 21 NO: C, 80.86; H, 7.92; N, 5.24. Found: C, 80.74; H, 7.91; N, 5.12; v 
